Denali Therapeutics, Inc. (DNLI)

17.02 +0.21 (+1.25%) USD  |  NASDAQ  |  Dec 18, 11:43
More

Denali Therapeutics EPS Basic from Continuing Operations (Quarterly)

EPS Basic from Continuing Operations (Quarterly) Chart

View EPS Basic from Continuing Operations (Quarterly) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Continuing Operations (Quarterly) Benchmarks

View EPS Basic from Continuing Operations (Quarterly) Benchmarks
Start Trial
Novavax, Inc. Upgrade
Agenus, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade